Evolving therapeutic landscape of advanced hepatocellular carcinoma
Shanghai Jiao Tong University · Renji Hospital · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
704
total citations
- FWCI
- 54.92
- Percentile
- 100%
- References
- 274
Citations per year
Authors
7- CYChen Yang
Shanghai Jiao Tong University, Renji Hospital, Shanghai Cancer Institute, State Key Laboratory of Oncogene and Related Genes
- HZHailin Zhang
Shanghai Jiao Tong University, Renji Hospital, Shanghai Cancer Institute, State Key Laboratory of Oncogene and Related Genes
- LZLinmeng Zhang
Shanghai Jiao Tong University, Renji Hospital, Shanghai Cancer Institute, State Key Laboratory of Oncogene and Related Genes
- AXAndrew X. ZhuCorresponding
Massachusetts General Hospital, Xinhui People's Hospital
- RBRené Bernards
Shanghai Jiao Tong University, Renji Hospital, Shanghai Cancer Institute, Oncode Institute, State Key Laboratory of Oncogene and Related Genes
Topics & keywords
Topics
Keywords
- Medicine
- Durvalumab
- Sorafenib
- Lenvatinib
- Targeted therapy
- Atezolizumab
- Bevacizumab
- Systemic therapy
No related works found for this paper.